SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 71.75 |
| Enterprise Value ($M) | 68.26 |
| Book Value ($M) | 29.14 |
| Book Value / Share | 0.90 |
| Price / Book | 2.46 |
| NCAV ($M) | 6.27 |
| NCAV / Share | 0.19 |
| Price / NCAV | 11.45 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.03 |
| Return on Assets (ROA) | -0.02 |
| Return on Equity (ROE) | -0.06 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.00 |
| Current Ratio | 2.41 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 34.22 |
| Assets | 57.08 |
| Liabilities | 27.95 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 11.10 | 5.95 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 81,276 | 363,273 | 22.37 | |
| 69,536 | 299,848 | 23.19 | |
| 195,096 | 747,106 | 26.11 | |
| 426,251 | 1,285,871 | 33.15 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| REVB – Revelation Biosciences, Inc. | RGC – Regencell Bioscience Holdings Limited |
| RGLS – Regulus Therapeutics Inc. | RNAZ – TransCode Therapeutics, Inc. |
| RNXT – RenovoRx, Inc. |
Financial data and stock pages provided by
Fintel.io